Zhai Xiaowen

Professional Biography

Dr. Zhai Xiaowen is Chief Physician in Pediatric Hematology & Oncology at Children's Hospital of Fudan University, Shanghai. Zhai serves as Vice-Chair, National Children's Leukemia Expert Committee (全国儿童白血病专家委员会). Clinical expertise includes Childhood acute lymphoblastic leukemia (ALL) — diagnosis, risk stratification, chemotherapy protocols, Childhood acute myeloid leukemia (AML) — induction, consolidation, and salvage therapy, Philadelphia chromosome-positive ALL in children — targeted therapy with TKIs, Anemias of various types (aplastic, hemolytic, nutritional). Co-investigator on landmark JAMA Oncology study (2020) demonstrating superiority of dasatinib over imatinib in pediatric Philadelphia chromosome-positive ALL — practice-changing finding that influenced international childhood ALL treatment guidelines (PMID: 31944221, 280+ citations). International fellowship, Division of Blood/Oncology, Cincinnati Children's Hospital, USA (2006) — one of North America's leading pediatric hematology-oncology programs; supported by the Baobao Exchange Scholar Fund. China Hospital Association Innovation Award and Shanghai Medical Science & Technology Award — institutional and municipal recognition for contributions to pediatric hematology-oncology research.